Clinical Trial Update: Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) [Phase 3]

View source ↗

Summary

This update reports long-term clinical outcomes from a Phase 3, multicenter study of subcutaneous immune globulin IgPro20 in Japanese subjects with primary immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• IgPro20 (Hizentra) (immune globulin, human, subcutaneous)

Snippet

Sponsor: CSL Behring | Conditions: Primary Immune Deficiency | Phase 3 | Status: COMPLETED